These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2137979)

  • 1. Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.
    Barbieri RL
    Am J Obstet Gynecol; 1990 Feb; 162(2):593-5. PubMed ID: 2137979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: a pilot study.
    Friedman AJ
    Fertil Steril; 1989 Mar; 51(3):526-8. PubMed ID: 2537769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone agonists: strategies for managing the hypoestrogenic effects of therapy.
    Judd HL
    Am J Obstet Gynecol; 1992 Feb; 166(2):752-6. PubMed ID: 1531578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
    Cedars MI; Lu JK; Meldrum DR; Judd HL
    Obstet Gynecol; 1990 Apr; 75(4):641-5. PubMed ID: 2138265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis.
    Friedman AJ; Lobel SM; Rein MS; Barbieri RL
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1114-9. PubMed ID: 2145765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy.
    Soliman AM; Bonafede M; Farr AM; Castelli-Haley J; Winkel C
    J Manag Care Spec Pharm; 2016 May; 22(5):573-87. PubMed ID: 27123918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimising menopausal side effects whilst treating endometriosis and fibroids.
    Simpson PD; McLaren JS; Rymer J; Morris EP
    Post Reprod Health; 2015 Mar; 21(1):16-23. PubMed ID: 25802141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri.
    Friedman AJ; Barbieri RL; Doubilet PM; Fine C; Schiff I
    Fertil Steril; 1988 Mar; 49(3):404-9. PubMed ID: 2963759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gonadotropin-releasing hormone analogs].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 May; 18(107):585-9. PubMed ID: 16161962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of gonadotropin-releasing hormone-agonists together with other drugs for medical treatment and prevention.
    Schindler AE
    Gynecol Endocrinol; 2009 Dec; 25(12):765-7. PubMed ID: 19905992
    [No Abstract]   [Full Text] [Related]  

  • 12. [Estrogen-progesterone "add-back" for long-term GNRH analogue therapy].
    Levy T; Ben-Rafael Z
    Harefuah; 1995 Jun; 128(12):789-92. PubMed ID: 7557691
    [No Abstract]   [Full Text] [Related]  

  • 13. The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial.
    Sadler Gallagher J; Feldman HA; Stokes NA; Laufer MR; Hornstein MD; Gordon CM; DiVasta AD
    J Pediatr Adolesc Gynecol; 2017 Apr; 30(2):215-222. PubMed ID: 26927501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial.
    Surrey ES; Judd HL
    J Clin Endocrinol Metab; 1992 Aug; 75(2):558-63. PubMed ID: 1386374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists.
    Adamson GD
    Am J Obstet Gynecol; 1992 Feb; 166(2):746-51. PubMed ID: 1531577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Add-back therapy use and its impact on LA persistence in patients with endometriosis.
    Fuldeore MJ; Marx SE; Chwalisz K; Smeeding JE; Brook RA
    Curr Med Res Opin; 2010 Mar; 26(3):729-36. PubMed ID: 20092387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum CA 125 concentrations in women with endometriosis or uterine fibroids treated with gonadotrophin-releasing hormone agonist analogues.
    van der Spuy ZM; Wood M; Fieggen G; Hendricks MS
    S Afr Med J; 1993 Jul; 83(7):510-3. PubMed ID: 8211493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined oestrogen-progestin treatment of vaginal haemorrhage following gonadotrophin-releasing hormone agonist therapy of uterine myomas.
    Friedman AJ
    Hum Reprod; 1993 Apr; 8(4):540-2. PubMed ID: 8501181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years.
    Friedman AJ; Daly M; Juneau-Norcross M; Gleason R; Rein MS; LeBoff M
    Hum Reprod; 1994 Sep; 9(9):1618-25. PubMed ID: 7836510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.